4.7 Article

HCH6-1, an antagonist of formyl peptide receptor-1, exerts anti-neuroinflammatory and neuroprotective effects in cellular and animal models of Parkinson?s disease

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Cell Biology

Role of Microgliosis and NLRP3 Inflammasome in Parkinson's Disease Pathogenesis and Therapy

Fillipe M. de Araujo et al.

Summary: Parkinson's disease is a neurodegenerative disorder characterized by motor symptoms, with pre-motor symptoms potentially preceding them. While the clinical characteristics of PD are well-defined, its pathogenesis is not fully understood, with inflammation and microglial activation believed to play key roles.

CELLULAR AND MOLECULAR NEUROBIOLOGY (2022)

Article Neurosciences

Inflammasome Signaling in the Aging Brain and Age-Related Neurodegenerative Diseases

Subhashini Brahadeeswaran et al.

Summary: Inflammasomes are important protein complexes in cells that play a critical role in maintaining homeostasis and responding to stimuli. Their activation leads to inflammation, cell death, and neuroinflammation, which are associated with aging and neurodegenerative diseases.

MOLECULAR NEUROBIOLOGY (2022)

Review Biochemistry & Molecular Biology

Emerging contributions of formyl peptide receptors to neurodegenerative diseases

Lukas Busch et al.

Summary: Inflammation plays a central role in neurodegenerative diseases, and formyl peptide receptors (FPRs) are key players in this process. FPRs trigger various signaling pathways that regulate immune and nervous system responses to inflammation. The interaction between FPRs and neuropathological and neuroprotective ligands, as well as their role in cell signaling pathways, are the focus of research.

BIOLOGICAL CHEMISTRY (2022)

Article Neurosciences

PTEN-Induced Putative Kinase 1 Dysfunction Accelerates Synucleinopathy

Tinh Thi Nguyen et al.

Summary: The loss of Pink1 function accelerates alpha-syn aggregation, accumulation, and glial activation, resulting in early and significant neurodegeneration and behavioral impairment in a PD mouse model. Our findings support the idea that PINK1 dysfunction increases the risk of synucleinopathy.

JOURNAL OF PARKINSONS DISEASE (2022)

Review Immunology

Neuroinflammation in Parkinson's Disease - Putative Pathomechanisms and Targets for Disease-Modification

Alexander Grotemeyer et al.

Summary: This article discusses the pathophysiology and neurodegeneration of Parkinson's disease, focusing on interconnected pathways related to the immune response. It also provides an overview of clinical trials targeting neuroinflammation in Parkinson's disease.

FRONTIERS IN IMMUNOLOGY (2022)

Review Clinical Neurology

Neurodegeneration and Neuroinflammation in Parkinson's Disease: a Self-Sustained Loop

G. Arena et al.

Summary: Neuroinflammation plays a significant role in the development of Parkinson's disease (PD), with potential involvement of mitochondrial dysfunction and impaired proteostasis. The cause of neuroinflammation in PD is still debated, but recent findings suggest the importance of intercellular communication and non-neuronal interactions in the disease. Aberrant activation of glial cells and other components of the immune system contribute to a vicious circle of neurodegeneration and neuroinflammation in PD. This review provides a summary of cellular alterations underlying neuroinflammation, including those induced by environmental factors and genetic background, and discusses potential clinical applications of immunobiomarkers and current therapeutic strategies for addressing inflammation in PD.

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2022)

Review Geriatrics & Gerontology

Mitochondrial Dysfunction in Parkinson's Disease: From Mechanistic Insights to Therapy

Xiao-Yan Gao et al.

Summary: Parkinson's disease is a common neurodegenerative movement disorder, and mitochondrial dysfunction is closely associated with its pathogenesis. There are currently no cures or preventative treatments for PD. Mitochondria play an important role in the pathology of PD and have become a promising therapeutic target.

FRONTIERS IN AGING NEUROSCIENCE (2022)

Review Cell Biology

Microglia Phenotypes in Aging and Neurodegenerative Diseases

Menbere Y. Wendimu et al.

Summary: Neuroinflammation plays a fundamental role in neurodegenerative diseases, and microglia, as the immune guardians of the central nervous system, are central drivers of this inflammation. Microglia exhibit complex and often contradictory activation patterns in different pathological states, playing both detrimental and protective roles.
Review Biochemistry & Molecular Biology

Mitochondrial Dysfunction and Mitophagy in Parkinson's Disease: From Mechanism to Therapy

Ana Belen Malpartida et al.

Summary: Mitochondrial dysfunction has long been associated with Parkinson's disease, although its exact role remains unclear. Recent discoveries on the role of PD familial genes in mediating mitophagy and the overlap with sporadic PD have opened up new opportunities for therapeutically targeting mitochondria in PD. Progress has also been made in understanding the upstream and downstream regulators of canonical and noncanonical PINK1/parkin-mediated mitophagy in response to mitochondrial damage.

TRENDS IN BIOCHEMICAL SCIENCES (2021)

Review Neurosciences

Parkinson's Disease: Can Targeting Inflammation Be an Effective Neuroprotective Strategy?

Vidar Gundersen

Summary: The exact cause of dopamine neuron death in Parkinson's disease is still largely unknown, but emerging evidence suggests a role for brain inflammation. Questions arise about whether intervening with brain inflammation early can slow down neuronal death, and if anti-inflammatory agents can effectively work. Data from human PD studies indicate that brain inflammation is an early event in PD, and the role of T-lymphocytes and peripheral inflammation in neurodegeneration is discussed. The failure of clinical trials targeting inflammation in PD is critically analyzed.

FRONTIERS IN NEUROSCIENCE (2021)

Review Neurosciences

The Role of Formyl Peptide Receptors in Neurological Diseases via Regulating Inflammation

Jiahui Zhu et al.

Summary: Formyl peptide receptors (FPRs) are important biomarkers for neurological diseases as they regulate inflammatory responses and affect neurological disease progression. FPRs have dual inflammatory functional properties in the central nervous system, with FPR2 mediating the active resolution of inflammation and FPR1 being related to angiogenesis, cell proliferation, and neurogenesis. Treatment with FPRs-modulation may be effective for neurological diseases.

FRONTIERS IN CELLULAR NEUROSCIENCE (2021)

Review Pharmacology & Pharmacy

Neurodegenerative Disease and the NLRP3 Inflammasome

Jonathan A. Holbrook et al.

Summary: The prevalence of neurodegenerative diseases is increasing, characterized by progressive neuronal loss, protein aggregation, metabolic abnormalities, and immune dysregulation. Research has shown that low-grade systemic inflammation may impact the development and progression of these diseases, and inflammation may also be a causative factor.

FRONTIERS IN PHARMACOLOGY (2021)

Review Neurosciences

Microglia in Neuroinflammation and Neurodegeneration: From Understanding to Therapy

Luca Muzio et al.

Summary: Microglia are resident macrophages of the central nervous system, playing a crucial role in immune defense in the brain. They support cell proliferation of neural precursors during brain development and preserve the integrity of neuronal circuits by sculpting synapses in post-natal life. Their functions change after CNS injury, but the precise role in neurological disorders is still not fully understood. There is evidence suggesting that regulating microglia functions could be a potential strategy for future therapies in neurodegenerative disorders such as multiple sclerosis, Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.

FRONTIERS IN NEUROSCIENCE (2021)

Review Biochemistry & Molecular Biology

The Contribution of Microglia to Neuroinflammation in Parkinson's Disease

Katja Badanjak et al.

Summary: With the aging population, the incidence of Parkinson's disease is increasing, with inflammatory processes playing a major role in its pathology. Microglia have been shown to have a significant neuroprotective role in PD, and the progression of PD may be driven by a vicious cycle between dying neurons and microglia.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Multidisciplinary Sciences

Soluble α-synuclein-antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia

Dorit Trudler et al.

Summary: Parkinson's disease is associated with the accumulation of alpha-synuclein and activation of microglia, potentially leading to neuronal death. This study shows that alpha-synuclein can activate NLRP3 inflammasome in human microglia and that alpha-synuclein-antibody complexes can exacerbate inflammation in a human context.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Pharmacology & Pharmacy

3′-Sialyllactose Protects SW1353 Chondrocytic Cells From Interleukin-1β-Induced Oxidative Stress and Inflammation

Ahreum Baek et al.

Summary: 3'-Sialyllactose showed therapeutic effects in interleukin-1 beta-treated chondrocytic cells through suppression of oxidative stress and inflammation, inhibition of apoptosis, and protection against cartilage destruction. Its mechanism of action involved modulation of antioxidant defense system and inflammatory responses.

FRONTIERS IN PHARMACOLOGY (2021)

Review Clinical Neurology

Targeting Inflammasomes to Treat Neurological Diseases

Jan D. Luenemann et al.

Summary: Inflammasomes are important protein complexes involved in innate immunity, processing and secretion of proinflammatory cytokines, and inducing a form of cell death associated with various central nervous system diseases. Pharmacological compounds targeting inflammasome activation show therapeutic efficacy in preclinical models of neurological disorders.

ANNALS OF NEUROLOGY (2021)

Article Cell Biology

Formyl peptide receptor 1 signaling potentiates inflammatory brain injury

Zhiguo Li et al.

Summary: Research found that FPR1 orchestrates brain inflammation after ICH by activating microglia, exacerbating brain damage. The FPR1 antagonist T-0080 can alleviate brain edema and improve neurological outcomes.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Review Clinical Neurology

The Pathogenesis of Parkinson's Disease: A Complex Interplay Between Astrocytes, Microglia, and T Lymphocytes?

Adina N. MacMahon Copas et al.

Summary: Parkinson's disease is a neurodegenerative disorder characterized by both motor and non-motor symptoms, including neuroinflammation and degeneration of dopaminergic neurons. In addition to the role of glial cells in maintaining CNS homeostasis, recent evidence suggests that peripheral immune cells, particularly T lymphocytes, play a significant role in the pathogenesis of the disease.

FRONTIERS IN NEUROLOGY (2021)

Review Clinical Neurology

Parkinson disease

R. Balestrino et al.

EUROPEAN JOURNAL OF NEUROLOGY (2020)

Review Clinical Neurology

Targeting the microglial NLRP3 inflammasome and its role in Parkinson's disease

Md Ezazul Haque et al.

MOVEMENT DISORDERS (2020)

Article Immunology

Inhibition of formyl peptide receptors improves the outcome in a mouse model of Alzheimer disease

Nicole Schroeder et al.

JOURNAL OF NEUROINFLAMMATION (2020)

Review Cell Biology

The Balance of TNF Mediated Pathways Regulates Inflammatory Cell Death Signaling in Healthy and Diseased Tissues

Joshua D. Webster et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Article Cell Biology

LRRK2 mediates microglial neurotoxicity via NFATc2 in rodent models of synucleinopathies

Changyoun Kim et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

Review Cell Biology

The N-formyl peptide receptors: contemporary roles in neuronal function and dysfunction

Peter J. G. Cussell et al.

NEURAL REGENERATION RESEARCH (2020)

Article Biochemistry & Molecular Biology

MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration

Eunju Lee et al.

CELL DEATH AND DIFFERENTIATION (2019)

Article Neurosciences

Loss of Microglial Parkin Inhibits Necroptosis and Contributes to Neuroinflammation

Pedro Eloi Antunes Dionisio et al.

MOLECULAR NEUROBIOLOGY (2019)

Article Neurosciences

C9orf72 is essential for neurodevelopment and motility mediated by Cyclin G1

Tu-Hsueh Yeh et al.

EXPERIMENTAL NEUROLOGY (2018)

Review Immunology

Formyl-Peptide Receptors in Infection, Inflammation, and Cancer

Elisabeth Weiss et al.

TRENDS IN IMMUNOLOGY (2018)

Article Cell Biology

Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice

Richard Gordon et al.

SCIENCE TRANSLATIONAL MEDICINE (2018)

Article Biochemistry & Molecular Biology

Dipeptide HCH6-1 inhibits neutrophil activation and protects against acute lung injury by blocking FPR1

Shun-Chin Yang et al.

FREE RADICAL BIOLOGY AND MEDICINE (2017)

Article Biochemistry & Molecular Biology

Formyl Peptide Receptor 1-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination

Kai Bihler et al.

JOURNAL OF MOLECULAR NEUROSCIENCE (2017)

Review Neurosciences

The SH-SY5Y cell line in Parkinson's disease research: a systematic review

Helena Xicoy et al.

MOLECULAR NEURODEGENERATION (2017)

Review Biochemistry & Molecular Biology

The Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition

Hui-Qiong He et al.

MOLECULES (2017)

Review Biochemistry & Molecular Biology

α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies

Yvette C. Wong et al.

NATURE MEDICINE (2017)

Review Biochemistry & Molecular Biology

Genetics in Parkinson disease: Mendelian versus non-Mendelian inheritance

Dena G. Hernandez et al.

JOURNAL OF NEUROCHEMISTRY (2016)

Article Clinical Neurology

Cdk5-Dependent Activation of Neuronal Inflammasomes in Parkinson's Disease

Pei Zhang et al.

MOVEMENT DISORDERS (2016)